D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin
CAT:
952-MDP0591
Size:
500 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
![D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin - image 1](/gentaur-product-1.webp)
![D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin - image 1](/gentaur-product-1.webp)
D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin
Description:
D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin Catalog number: MDP0591 CAS Number: 107452-89-1 Sequence: D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg (Thi: L-Thienylalanine) Amount: 500 ug Molecular Weight: 1294.4 g/mol Supplied as: Powder Applications: molecular tool for various biochemical applications Storage: -20 °C WARNING: For in vitro Research Use Only. NOT for use on humans or animals. Grade: Biotechnology grade. All products are highly pure. References: 1: Jan CR, Ho CM, Wu SN, Tseng CJ. Bradykinin-evoked Ca2+ mobilization in Madin Darby canine kidney cells Eur J Pharmacol. 1998 Aug 21;355(2-3):219-33. 2: Lavich TR, Cordeiro RS, Calixto JB, e Silva PM, Martins MA. Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats Eur J Pharmacol. 2003 Feb 21;462(1-3):185-92. 3: Srinivasan D, Burbach LR, Daniels DV, Ford AP, Bhattacharya A. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate Br J Pharmacol. 2004 May;142(2):297-304. 4: Tanaka Y, Nagai M, Date T, Okada T, Abe Y, Seki S, Taniguchi M, Taniguchi I, Mochizuki S. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats Hypertens Res. 2004 Nov;27(11):865-75. 5: Szabó A, Helyes Z, Sándor K, Bite A, Pintér E, Németh J, Bánvölgyi A, Bölcskei K, Elekes K, Szolcsányi J. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice J Pharmacol Exp Ther. 2005 Jul;314(1):111-9. 6: Hao Y, Okamura S, Wang LM, Mineshita S. The involvement of bradykinin in adrenaline-induced pulmonary edema in rats J Med Dent Sci. 2001 Sep;48(3):79-85. 7: Srinivasan D, Kosaka AH, Daniels DV, Ford AP, Bhattacharya A. Pharmacological and functional characterization of bradykinin B2 receptor in human prostate Eur J Pharmacol. 2004 Nov 19;504(3):155-67. 8: Hayashi K, Ishikawa T, Yamashita T, Tajima T, Nakayama K. Biphasic response of cutaneous blood flow induced by passive cutaneous anaphylaxis in rats Eur J Pharmacol. 2003 Dec 15;482(1-3):305-11. 9: Krstew E, Jarrott B, Lawrence AJ. Bradykinin B2 receptors in nodose ganglia of rat and human Eur J Pharmacol. 1998 May 8;348(2-3):175-80. 10: Green BT, Calvin A, O'Grady SM, Brown DR. Kinin-induced anion-dependent secretion in porcine ileum: characterization and involvement of opioid- and cannabinoid-sensitive enteric neural circuits J Pharmacol Exp Ther. 2003 May;305(2):733-9.
Products Related to D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin can be found at PeptidesShort Description:
Catalog Number: MDP0591 (500 ug) D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin is a high quality D-Arginyl-[Hyp3,Thi5,8,D-Phe7]-Bradykinin. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.Weight:
0.15Length:
2Width:
0.5Height :
0.5